Latest Capital Raises News

Southern Palladium's latest metallurgical test work from its Bengwenyama PGM Project reveals a doubling in chromite concentrate recoveries and confirms the high-grade nature of its UG2 mineral resource, reshaping project economics and processing design.

Cobre Limited has kicked off a major 40,000-metre drilling campaign at its Sierra Atacama copper project in Chile, aiming to convert its existing NI 43-101 resource to JORC compliance and explore opportunities for a larger open-pit operation.

Hiremii Limited has landed its initial paying customers for its AI-powered workforce intelligence platform, marking a pivotal step in its shift from recruitment services to a SaaS technology provider in energy and infrastructure sectors.

Evolution Mining (ASX: EVN) ended March 2026 with a net cash position of $42 million and a $1.37 billion cash balance, driven by strong cash flow from high-margin operations and on-track production.

Aurum Resources has consolidated a 4.2 million ounce gold resource across its Boundiali and Napié projects in Côte d’Ivoire, progressing a central processing hub and expanding drilling programs as it targets development milestones in 2026.

Critical Resources has defined a focused 2026 exploration program at its Mavis Lake lithium project while confirming an orogenic gold system in New Zealand and delivering promising early results from its solid-state lithium-ion battery evaluation.

Westar Resources is pressing forward with its Mageye anomaly exploration in WA's Murchison region while negotiating heritage agreements and managing a $1.15 million cash balance. The company also secured new tenements in the Northern Territory and awaits shareholder approval for a $1.49 million capital raise.

Comvita launches a NZ$30 million renounceable Rights Offer to refinance debt and bring Southeast Asian consumer giant Fraser and Neave onboard as a strategic investor with a near 20% stake.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Percheron Therapeutics has closed a $2.2 million entitlement offer to advance its HMBD-002 immuno-oncology candidate towards a phase II trial in 2026, backed by strong shareholder and new investor support.

Truscott Mining’s maiden 2026 drilling at Westminster confirms shear-hosted gold mineralisation and sets the stage for diamond drilling and resource upgrades. Management changes and mining lease applications signal a push towards production.

Cuscal Limited is set to acquire New Zealand payments provider Paymark for A$27 million, funded by a fully underwritten A$30 million institutional placement and a non-underwritten A$3 million share purchase plan. The deal, expected to complete by June 2026, will add scale and geographic diversification while being accretive to earnings in FY27.